These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6404980)

  • 1. A guide to benefit-cost analysis, as seen through a controlled experiment in treating the mentally ill.
    Weisbrod BA
    J Health Polit Policy Law; 1983; 7(4):808-45. PubMed ID: 6404980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit-cost analysis of a controlled experiment: treating the mentally ill.
    Weisbrod BA
    J Hum Resour; 1981; 16(4):523-48. PubMed ID: 6799568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is there a disproportional increase in health care costs for schizophrenic patients?].
    Salize HJ; Rössler W
    Nervenarzt; 1999 Sep; 70(9):817-22. PubMed ID: 10522250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of research on the costs of institutional and community-based care.
    Mitchell D; Braddock D; Hemp R
    J Ment Health Adm; 1990; 17(2):171-83. PubMed ID: 10107494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost and outcomes of community-based care for the seriously mentally ill.
    Dickey B; Fisher W; Siegel C; Altaffer F; Azeni H
    Health Serv Res; 1997 Dec; 32(5):599-614. PubMed ID: 9402903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of economic evaluations of community mental health care.
    Roberts E; Cumming J; Nelson K
    Med Care Res Rev; 2005 Oct; 62(5):503-43. PubMed ID: 16177456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of alternative approaches in treating severely mentally ill in California.
    Hu TW; Jerrell J
    Schizophr Bull; 1991; 17(3):461-8. PubMed ID: 1947870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost comparison of institutional and community based alternatives for mentally retarded persons.
    Intagliata JC; Wilder BS; Cooley FB
    Ment Retard; 1979 Jun; 17(3):154-6. PubMed ID: 542121
    [No Abstract]   [Full Text] [Related]  

  • 9. Benefit-cost analysis of community residential versus institutional services for adults with severe mental retardation and challenging behaviors.
    Knobbe CA; Carey SP; Rhodes L; Horner RH
    Am J Ment Retard; 1995 Mar; 99(5):533-41. PubMed ID: 7779348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of state hospital and community-based care for seriously mentally ill adults.
    Rothbard AB; Schinnar AP; Hadley TP; Foley KA; Kuno E
    Am J Psychiatry; 1998 Apr; 155(4):523-9. PubMed ID: 9545999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Institutionalisation-index--a simple method to estimate direct treatment costs for institutionalised forms of community mental health care].
    Priebe S; Dielentheis TF
    Psychiatr Prax; 2002 Nov; 29(8):420-3. PubMed ID: 12436362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The editor's perspective on institutional and community costs.
    Taylor SJ
    Ment Retard; 2003 Apr; 41(2):125-6. PubMed ID: 12622531
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring the economic costs of schizophrenia.
    McGuire TG
    Schizophr Bull; 1991; 17(3):375-88. PubMed ID: 1947861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative to mental hospital treatment. II. Economic benefit-cost analysis.
    Weisbrod BA; Test MA; Stein LI
    Arch Gen Psychiatry; 1980 Apr; 37(4):400-5. PubMed ID: 6767462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAND study first to document costs and fiscal impact of a mental health court.
    Psychiatr Serv; 2007 Apr; 58(4):577. PubMed ID: 17469238
    [No Abstract]   [Full Text] [Related]  

  • 16. [The influence of community support services on the costs of treatment of chronically mentally ill patients].
    Załuska M; Suchecka D; Traczewska Z; Paszko J
    Psychiatr Pol; 2004; 38(5):911-22. PubMed ID: 15523936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance abuse in schizophrenia: service utilization and costs.
    Bartels SJ; Teague GB; Drake RE; Clark RE; Bush PW; Noordsy DL
    J Nerv Ment Dis; 1993 Apr; 181(4):227-32. PubMed ID: 8473874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs and benefits of screening for PKU in Wisconsin.
    Barden HS; Kessel R; Schuett VE
    Soc Biol; 1984; 31(1-2):1-17. PubMed ID: 6443326
    [No Abstract]   [Full Text] [Related]  

  • 19. Enrollment duration, service use, and costs of care for severely mentally ill members of a health maintenance organization.
    McFarland BH; Johnson RE; Hornbrook MC
    Arch Gen Psychiatry; 1996 Oct; 53(10):938-44. PubMed ID: 8857871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the level of institutionalisation found in psychiatric housing services associated with the severity of illness and the functional impairment of the patients? A patient record analysis.
    Valdes-Stauber J; Kilian R
    BMC Psychiatry; 2015 Sep; 15():215. PubMed ID: 26370719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.